- Home
- BFRI vs ADIL Comparison
BFRI vs ADIL Comparison
Compare BFRI & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFRI | ADIL |
|---|---|---|
| Founded | 1997 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3M | 18.5M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BFRI | ADIL |
|---|---|---|
| Price | $1.36 | $5.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.75 | ★ $37.50 |
| AVG Volume (30 Days) | ★ 696.4K | 64.8K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.70 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $41,705,000.00 | N/A |
| Revenue This Year | $14.36 | N/A |
| Revenue Next Year | $16.98 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 11.75 | N/A |
| 52 Week Low | $0.57 | $0.13 |
| 52 Week High | $1.66 | $7.20 |
Technical Indicators
Market Signals| Indicator | BFRI | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 51.98 | 46.30 |
| Support Level | $0.78 | $1.63 |
| Resistance Level | N/A | $5.08 |
| Average True Range (ATR) | 0.11 | 0.63 |
| MACD | -0.02 | -0.21 |
| Stochastic Oscillator | 33.31 | 8.12 |
Price Performance
Historical ComparisonAbout BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.